by Igor Hajdukovic | Oct 17, 2026 | Uncategorized
The most advanced device isn’t automatically the right choice for a patient with dry eye. Effective dry eye disease management technology should be selected according to the clinical presentation and likely underlying mechanisms, not novelty alone. Meibomian gland...
by Igor Hajdukovic | Oct 16, 2026 | Uncategorized
What does “plasma” mean in ophthalmology: a blood-derived therapy, an ionized gas, or a device-based treatment? The distinction matters. Plasma technology for ophthalmology covers different mechanisms, and the label alone does not explain how a technology works or...
by Igor Hajdukovic | Oct 15, 2026 | Uncategorized
A plasma device that appears technically similar to another may not be suitable for the same clinical purpose. Evaluating advanced plasma technology for clinics starts with fit: the device’s operating principles, authorized use, and intended application must align...
by Igor Hajdukovic | Oct 14, 2026 | Uncategorized
Can research on one device support claims about a plasma pen for xanthelasma treatment? Not automatically. Evidence about one plasma device or technique doesn’t establish the safety or effectiveness of every pen on delicate eyelid skin. A confident diagnosis and...
by Igor Hajdukovic | Oct 13, 2026 | Uncategorized
The largest equipment catalogue may be the least useful place to start. For Canadian clinics, choosing medical aesthetics equipment Canada-wide is less about the number of options and more about whether a device fits the practice’s clinical scope, patient needs,...
